Skip to main content

Parkwalk Advisors — Portfolio, Page 5

Investor actively backing innovative startups and growth-stage companies across various industries and funding rounds.

173
Companies
$1.8B
Total invested
$12.2M
Avg. check
45
Industries
Biotechnology 8Health Care 5Software 5Manufacturing 5Medical 4Artificial Intelligence (AI) 3+39 more
Founder contacts

Verified emails & LinkedIn for founders across this portfolio.

jane@on●●●●●●●.com
linkedin.com/in/●●●●●●
Verified contacts, updated monthly
Get instant access →

Portfolio companies

Showing 97120 of 173
Scripta Therapeutics
November 2025

Scripta Therapeutics operates as a bio-tech company.

Biotechnology · Oxford$12.0M Seed
Sphere Bio
October 2021

Sphere Bio specializes in tools for single cell analysis and isolation, facilitating discovery in the biotech field.

Biotechnology · Cambridge$41.4M Venture - Series Unknown
Ikarovec
October 2024

Ikarovek is working on early stage assets intended for the treatment of diabetic macular edama.

Biotechnology · Cambridge$10.3M Seed
Oxa
March 2026

Oxa develops autonomous vehicle software and hardware solutions for industrial mobility automation.

Artificial Intelligence (AI) · Oxford$102.6M Series D
xWatts
February 2026

xWatts is an intelligent energy management system that helps commercial buildings reduce costs and emissions.

Energy Management · London$2.2M Seed
Fresh Check
December 2025

Visible warning of bacterial infection in packaging.

Fitness · London$201K Series Unknown
Echopoint Medical
December 2025

Echopoint Medical is a medtech company

Health Care · London$250K Series Unknown
NoBACZ
September 2025

NoBACZ is pioneering a novel, new precision bandaging platform for the veterinary and human market.

Health Care · Cambridge$6.4M Series Unknown
Trismik
September 2025

Trismik is an early-stage company specializing in efficient real-world evaluations, particularly for LLMs.

Information Technology · Cambridge$3.0M Pre-Seed
Enhanc3D Genomics
September 2025

Enhanc3D Genomics is a functional genomics company exploring the 3D organization of DNA in health and disease.

Biotechnology · Cambridge$5.4M Series A
Xampla
September 2025

Xampla develops natural, biodegradable materials as sustainable alternatives to traditional plastics.

Biotechnology · Cambridge$14.0M Series A
Paragraf
August 2025

Paragraf develops and manufactures graphene-based electronic devices for the sensors and diagnostics markets.

Advanced Materials · Somersham$55.0M Series C
Bitfount
July 2025

Federated data science and AI platform for privacy-preserving analytics & AI/ML

Analytics · London$8.0M Series A
Zentraxa
May 2025

Zentraxa has specialise in the design, production and testing of complex novel peptides.

Biotechnology · BristolSeed
Psyomics
April 2025

PsyOmics develops proteomic diagnostics to improve early diagnosis and treatment outcomes for those with neuropsychiatric disorders.

Biotechnology · CambridgeNon Equity Assistance
OSSTEC
March 2025

The next step forward in orthopaedics

3D Printing · London$3.2M Seed
Cambridge Electric Cement
March 2025

Cambridge Electric Cement is a sustainable cement start-up.

Building Material · CambridgeNon Equity Assistance
Cambridge GaN Devices
February 2025

Cambridge GaN Devices is a semiconductor company focused on developing GaN power devices aimed at creating greener electronics.

Electronics · Cambridge$32.0M Series C
RoboK
January 2025

RoboK is a computer vision startup with a mission to make all industrial workplaces safe and high-performing with AI.

Artificial Intelligence (AI) · Cambridge$1.1M Grant
Illumion
December 2024

Illumion developes a lab-based real-time measurement device designed to offer detailed insights into energy storage processes.

Energy · Cambridge$2.7M Seed
Abselion
December 2024

Abselion is the biological sensor for rapid and cost-effective detection of biological substances.

Biotechnology · Cambridge$8.4M Series A
Echion Technologies
November 2024

Echion Technologies develops XNO anode materials designed for Li-ion batteries used in heavy-duty electric vehicles.

Battery · Cambridge$12.6M Series Unknown
Barocal
October 2024

Barocal is a refrigeration technology company that develops solid-state cooling and heating systems for efficient cooling.

Energy · London$2.7M Grant
Cheesecake Energy
September 2024

Cheesecake Energy is developing advanced thermal and compressed air energy systems to store energy.

Energy · NottinghamGrant

Where Parkwalk Advisors invests

Biotechnology8
Health Care5
Software5
Manufacturing5
Medical4
Artificial Intelligence (AI)3

About Parkwalk Advisors's portfolio

How many companies has Parkwalk Advisors invested in?

Parkwalk Advisors has invested in 173 companies tracked in our database. The portfolio spans multiple industries and funding stages, from seed-stage startups to late-stage companies.

What industries does Parkwalk Advisors invest in?

Parkwalk Advisors's top investment sectors include Biotechnology, Health Care, Software, Manufacturing, Medical. The firm invests across 45 different industry categories.

What is Parkwalk Advisors's largest investment?

Among tracked funding rounds, Oxa received $102.6M in a Series D round. Parkwalk Advisors's total known invested capital is $1.8B.

What is the average investment size for Parkwalk Advisors?

Parkwalk Advisors's average investment size is $12.2M across its portfolio of 173 companies.

What are Parkwalk Advisors's most recent investments?

Recent Parkwalk Advisors portfolio additions include Scripta Therapeutics, Sphere Bio, Ikarovec, Oxa, xWatts. These companies were founded in 2020 or later.

Reach the founders behind these 173 companies
Verified emails and LinkedIn profiles, updated monthly.
Get instant access →